1-45514954-T-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_181697.3(PRDX1):c.302A>G(p.Asn101Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000185 in 1,614,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_181697.3 missense
Scores
Clinical Significance
Conservation
Publications
- methylmalonic aciduria and homocystinuria type cblCInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRDX1 | NM_181697.3 | c.302A>G | p.Asn101Ser | missense_variant | Exon 4 of 6 | ENST00000319248.13 | NP_859048.1 | |
PRDX1 | NM_001202431.2 | c.302A>G | p.Asn101Ser | missense_variant | Exon 4 of 6 | NP_001189360.1 | ||
PRDX1 | NM_002574.4 | c.302A>G | p.Asn101Ser | missense_variant | Exon 4 of 6 | NP_002565.1 | ||
PRDX1 | NM_181696.3 | c.302A>G | p.Asn101Ser | missense_variant | Exon 4 of 6 | NP_859047.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152242Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000477 AC: 12AN: 251468 AF XY: 0.0000441 show subpopulations
GnomAD4 exome AF: 0.000192 AC: 281AN: 1461872Hom.: 0 Cov.: 31 AF XY: 0.000184 AC XY: 134AN XY: 727240 show subpopulations
GnomAD4 genome AF: 0.000112 AC: 17AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74380 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.302A>G (p.N101S) alteration is located in exon 4 (coding exon 3) of the PRDX1 gene. This alteration results from a A to G substitution at nucleotide position 302, causing the asparagine (N) at amino acid position 101 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with PRDX1-related conditions. This variant is present in population databases (rs201400424, gnomAD 0.01%). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 101 of the PRDX1 protein (p.Asn101Ser). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at